Procaps Group SA (PROC): Rasio rega marang dodolan

Simbol lan logo merek Procaps Group (PROC)

Procaps Group S.A. (PROC) minimizes risks through a combination of proprietary brands and third-party orders. The company's market capitalization-to-revenue ratio visualizes market demand for the business, where 0.60 represents the latest level. Revenues are based on the production of softgels and CDMO services. Long-term B2B contracts in Latin America ensure a stable cash flow, supporting the enterprise's operational resilience.

PROC: Rasio rega marang pendapatan Procaps Group SA 04.07.2022 - 31.12.2024

Rincian analitis perusahaan Procaps Group SA (PROC)

- rega saham lan konsensus proyeksi valuasi:
Bagan owah-owahan rega procapsgroup.com|PROC - Bagan rega target
- data kapitalisasi bursa:
Biji pasar Procaps Group SA|PROC - Nilai Total Perusahaan
- indikator nilai aset resik miturut neraca:
Nilai Akuntansi Saham Procaps|PROC - Nilai Buku Perusahaan|Koefisien Nilai Pasar marang Nilai Buku procapsgroup.com|PROC - Total Aset Perusahaan
- indikator beban kredit lan likuiditas emiten:
Rasio Total Utang marang Ekuitas Procaps Group S.A.|PROC - Utang jangka dawa marang modal|Utang jangka cendhak marang modal Procaps Group Corp|PROC - Utang perusahaan|Rasio utang-utang marang kapitalisasi buku Procaps Group SA|PROC - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Procaps|Rasio jangkoan perantara procapsgroup.com
- informasi bathi lan kelipatan valuasi:
PROC - Bathi resik|Proyeksi bathi resik Procaps Group S.A.|PROC - Rasio rega marang bathi|Pangali mangsa ngarep rega marang bathi Procaps Group|PROC - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Procaps Group SA|PROC - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) Procaps|PROC - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan procapsgroup.com|PROC - Wutah bathi resik saben saham ing taun iki|Dinamika bathi saben saham sing diarepake ing taun ngarep Procaps Group S.A.
- data total pendapatan lan volume dodolan:
PROC - Pendapatan perusahaan|Dodolan mangsa ngarep perusahaan procapsgroup.com|PROC - Kapitalisasi marang pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Procaps Group SA
Analisis fundamental perusahaan:procapsgroup.com - PROC
Produk asli Procaps Group SA

Stable demand for Procaps Group S.A. softgels creates a foundation for valuing the business via P/S, which measures the company's market value relative to its annual revenue. By analyzing the price-to-sales ratio, an investor can determine whether they are overpaying for current sales amid management risks and Latin American currency volatility.

Pesaing Procaps Group S.A.

HLN (haleon.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Kenvue KVUE|VRNA (Verona Pharma PLC) - Rasio rega marang dodolan|MENS - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan LGND (Ligand Corp)|Amneal Pharmaceuticals (AMRX) - Rasio rega marang pendapatan|Rega marang dodolan perrigo.com (PRGO)|ALVO (Alvotech SA) - Multiplikator P/S|Kapitalisasi marang pendapatan Liquidia Corp (LQDA)|Multiplikator P/S GLPG|Multiplikator P/S ANI Pharmaceuticals Corp (ANIP)|Rasio rega marang pendapatan MannKind Corporation MNKD|AMPH (amphastar.com) - Rasio rega marang dodolan|PCRX - Rasio rega marang pendapatan|Koefisien rega marang pendapatan ARS Pharmaceuticals Inc SPRY|TBPH (Theravance) - Kapitalisasi marang pendapatan|Aquestive Corp - Rasio kapitalisasi pasar marang pendapatan|SCPH (scPharmaceuticals, Inc.) - Multiplikator P/S|TECX - Multiplikator rega marang pendapatan|Rasio rega marang pendapatan Tonix Pharmaceuticals Holding Corp. (TNXP)|SXTC (sxtchina.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Eupraxia Pharmaceuticals Inc. EPRX|BioHarvest Sciences Inc (BHST) - Rega marang dodolan|EXOZ: Kapitalisasi marang pendapatan|ORMP - Multiplikator P/S|enterabio.com (ENTX) - Rasio rega marang pendapatan|Rasio rega marang dodolan HYFT (MindWalk Holdings, Inc.)|Kapitalisasi marang pendapatan ABVC|CPIX: Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Quantum BioPharma Ltd (QNTM)|Koefisien rega marang pendapatan fibrogen.com|Telomir Pharmaceuticals, Inc. - Kapitalisasi marang pendapatan|Koefisien rega marang pendapatan Rani Therapeutics Holdings (RANI)|Synergy CHC Corporation - Multiplikator P/S|RLYB - Multiplikator P/S|LEXX (lexariabioscience.com) - Kapitalisasi marang pendapatan|PULM - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Pheton Holdings Limited|Aptorum - Rasio rega marang dodolan|Rasio rega marang pendapatan Lyra Therapeutics, Inc (LYRA)|IBO (Impact BioMedical, Inc.) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan TNF Pharmaceuticals, Inc. TNFA|cbdMD Inc. (YCBD) - Rega marang dodolan|PainReform - Multiplikator P/S|Altamira Therapeutics (CYTO) - Kapitalisasi marang pendapatan|Lipella (LIPO) - Rasio rega marang pendapatan|Rasio rega marang dodolan OPTN (OptiNose Corp)|PIRS (Pieris Pharmaceuticals) - Multiplikator P/S|PTPI: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S QLI|Multiplikator P/S Acelyrin Inc. (SLRN)|Rasio rega marang pendapatan TFF Pharma TFFP